查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1606423

新抗原癌症疫苗市場，按產品、按類型、按給藥途徑、按傳遞機制、按應用、按國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Neoantigen Cancer Vaccine Market, By Product, By Type, By Route of Administration, By Delivery Mechanism, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 317 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023年新抗原癌症疫苗市場規模為460.5943億美元，2024年至2032年複合年成長率為73.40%。

新抗原癌症疫苗市場-市場動態

旨在客製化患者治療的個人化醫療的日益普及預計將推動市場擴張。這種方法強調制定專門針對個別患者特徵（例如遺傳特徵、腫瘤特徵和整體健康狀況）的治療計劃。該方法的核心是新抗原疫苗，它是根據患者腫瘤中發現的獨特突變精心製作的。值得注意的是，市場上的個人化藥物數量從 132 種增加到 286 種，這些療法佔 FDA 2019 年批准的新藥的 25%。

此外，公共和私營部門的資金增加，包括製藥公司和創投家的捐款，正在推動這一領域的研究和開發工作。然而，製造流程的複雜性可能會對市場成長構成挑戰。

新抗原癌症疫苗市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032）每年將以 73.40% 左右的複合年成長率成長

根據產品細分，個人化預計將在 2023 年顯示最大的市場佔有率

按類型分類，2023年核酸為主導類型

根據應用細分，2023年肺癌為主導類型

按地區分類，北美是 2023 年的主要收入來源

新抗原癌症疫苗市場-細分分析：

全球新抗原癌症疫苗市場根據產品、類型、給藥途徑、輸送機制、應用和地區進行細分。

市場根據產品分為兩個部分：個人化和現成的。個性化細分市場在市場上佔據主導地位。個人化新抗原疫苗通常與檢查點抑制劑（例如 PD-1 或​​ CTLA-4 抑制劑）合併使用，以增強免疫反應。這種組合策略正在研究中，以解決現有免疫療法的缺點並提高患者的治療效果。

市場依類型分為四大類：樹突狀細胞、核酸、合成長肽、腫瘤細胞。核酸品類在市場上處於領先地位。新抗原癌症疫苗市場與核酸技術的進步密切相關，特別是在開發旨在解決腫瘤特異性突變的新型疫苗方面。

根據給藥途徑，市場分為三類：肌肉注射、靜脈注射和經皮注射。新抗原癌症疫苗市場正在經歷顯著成長，不同的給藥途徑對於這些客製化療法的進步和推廣至關重要。

根據傳遞機制，市場分為四個部分：脂質體、病毒體、基因槍、電穿孔和其他。這些機制對於有效地將個人化疫苗遞送至目標細胞至關重要，從而促進對癌症特異性新抗原的強大免疫反應。

根據應用，市場分為四類：腦癌、胃腸癌、肺癌、黑色素瘤和其他。肺癌在市場上處於領先地位。就肺癌而言，突變負擔的增加提供了多種潛在的新抗原作為靶向，使個人化疫苗成為一種非常有前途的方法。

新抗原癌症疫苗市場-地理洞察

北美擁有健全的臨床試驗框架，有許多研究機構和醫院從事新抗原疫苗的開發。該地區的監管環境有利於簡化試驗流程，促進創新療法的進步和評估。癌症幾乎影響了美國的每個人，公眾對增加癌症研究資金也給予了大力支持。 ASCO 最近進行的一項涉及 4,000 多名美國人的調查顯示，大約 73% 的人認為政府應該分配更多資源來發現癌症的治療方法，即使這需要提高稅收或增加國家赤字。在基因組技術進步的推動下，歐洲是第二大市場擴張地區。總體而言，新抗原癌症疫苗的全球環境充滿活力，在不同地區提供了大量的成長機會。

新抗原癌症疫苗市場-競爭格局：

新抗原癌症疫苗市場呈現出高度競爭的環境，主要參與者積極利用尖端技術、建立策略聯盟並在研發方面進行大量投資。這些公司正與研究機構、醫療機構和其他生技公司合作，加強研發力度，加速新抗原疫苗的研發。在持續的技術進步和提高患者治療效果的承諾的推動下，競爭格局預計將迅速發生變化。

最新進展：

2024 年 9 月 10 日，OSE Immunotherapeutics SA 宣布開始針對 Tedopi 進行名為「Artemia」的國際 3 期臨床試驗，Tedopi 是一種基於新表位的治療性癌症疫苗，旨在用於現成應用。該試驗旨在為診斷為轉移性非小細胞肺癌（NSCLC）的患者提供二線治療。該研究已獲得美國 FDA、加拿大、歐洲和英國等 14 個國家衛生當局的審查和批准，標誌著 Tedopi 的註冊流程以及 HLA 伴隨診斷的開發取得了重大進展-A2陽性患者。

目錄

第 1 章：新抗原癌症疫苗市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 新抗原癌症疫苗市場片段（按產品）
    • 新抗原癌症疫苗市場片段（按類型）
    • 按給藥途徑分類的新抗原癌症疫苗市場片段
    • 新抗原癌症疫苗市場片段（依傳遞機制）
    • 新抗原癌症疫苗市場片段（按應用）
    • 新抗原癌症疫苗市場片段（按國家/地區）
    • 按地區分類的新抗原癌症疫苗市場片段
  • 競爭洞察

第 3 章：新抗原癌症疫苗主要市場趨勢

  • 新抗原癌症疫苗市場促進因素
    • 市場促進因素的影響分析
  • 新抗原癌症疫苗市場限制
    • 市場限制影響分析
  • 新抗原癌症疫苗市場機會
  • 新抗原癌症疫苗市場未來趨勢

第 4 章：新抗原癌症疫苗產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：新抗原癌症疫苗市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：新抗原癌症疫苗市場格局

  • 2023 年新抗原癌症疫苗市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：新抗原癌症疫苗市場 - 副產品

  • 概述
    • 按產品分類的細分市場佔有率分析
    • 個人化
    • 現成的

第 8 章：新抗原癌症疫苗市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 樹突狀細胞
    • 核酸
    • 合成長胜肽
    • 腫瘤細胞

第 9 章：新抗原癌症疫苗市場 - 按給藥途徑

  • 概述
    • 按給藥途徑分類的細分市場佔有率分析
    • 肌肉注射
    • 靜脈
    • 經皮

第 10 章：新抗原癌症疫苗市場 - 按傳遞機制

  • 概述
    • 按交付機制分類的細分市場佔有率分析
    • 脂質體
    • 病毒體
    • 基因槍
    • 電穿孔
    • 其他

第 11 章：新抗原癌症疫苗市場 - 按應用

  • 概述
    • 按應用分類的細分市場佔有率分析
    • 腦癌
    • 胃腸癌
    • 肺癌
    • 黑色素瘤
    • 其他

第 12 章：新抗原癌症疫苗市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美新抗原癌症疫苗主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按產品）
    • 北美市場規模和預測（按類型）
    • 北美市場規模與預測（按管理途徑）
    • 北美市場規模和預測（按交付機制）
    • 北美市場規模和預測（按應用）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲新抗原癌症疫苗主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按產品）
    • 歐洲市場規模與預測（按類型）
    • 歐洲市場規模與預測（按管理途徑）
    • 歐洲市場規模和預測（按交付機制）
    • 歐洲市場規模和預測（按應用）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區新抗原癌症疫苗主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按產品）
    • 亞太地區市場規模與預測（按類型）
    • 亞太地區市場規模與預測（依管理途徑）
    • 亞太地區市場規模與預測（按交付機制）
    • 亞太地區市場規模與預測（按應用）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲新抗原癌症疫苗主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按產品）
    • 拉丁美洲市場規模與預測（按類型）
    • 拉丁美洲市場規模與預測（按管理途徑）
    • 拉丁美洲市場規模與預測（按交付機制）
    • 拉丁美洲市場規模與預測（按應用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲新抗原癌症疫苗主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按產品）
    • 中東和非洲市場規模及預測（按類型）
    • 中東和非洲市場規模及預測（按管理途徑）
    • 中東和非洲市場規模及預測（按交付機制）
    • 中東和非洲市場規模及預測（按應用）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 13 章：主要供應商分析-新抗原癌症疫苗產業

  • 競爭儀表板
  • 公司簡介
    • OSE Immunotherapeutics SA
    • Gritstone bio Inc.
    • BioNTech SE
    • Hoffmann-La Roche Ltd.
    • Pfizer Inc.
    • Merck & Co. Inc.
    • Moderna Inc.
    • Avidea Technologies Inc.
    • Eli Lilly and Company
    • Vaccibody AS
    • Agenus Inc.
    • Novogene Co. Ltd.
    • ZIOPHARM Oncology Inc.
    • ISA Pharmaceuticals BV
    • BrightPath Biotherapeutics Co. Ltd.
    • Vaximm AG
    • Medigene AG
    • Genocea Biosciences Inc.
    • Advaxis Inc.
    • Nouscom AG
    • Others

第 14 章：360 度分析師視角

第 15 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4229

REPORT HIGHLIGHT

The Neoantigen Cancer Vaccine Market size was valued at USD 46,059.43 million in 2023, expanding at a CAGR of 73.40% from 2024 to 2032.

Neoantigen cancer vaccines constitute a form of personalized immunotherapy aimed at activating the immune system to identify and combat cancerous cells. These vaccines focus on neoantigens, which are unique antigens generated from mutations within tumor cells. The development of neoantigen cancer vaccines marks a notable progression in the field of cancer immunotherapy, utilizing the distinct features of an individual's tumor to bolster the body's inherent capacity to combat cancer.

Neoantigen Cancer Vaccine Market- Market Dynamics

The growing adoption of personalized medicine aimed at customizing patient treatment is anticipated to propel market expansion. This approach emphasizes the development of treatment plans that are specifically designed to align with individual patient characteristics, such as genetic profiles, tumor features, and overall health status. Central to this methodology are Neoantigen vaccines, which are meticulously crafted based on the distinct mutations found in a patient's tumor. Notably, the number of personalized medicines available in the market increased from 132 to 286, with these therapies representing 25% of the new drugs approved by the FDA in 2019.

Moreover, enhanced funding from both public and private sectors, including contributions from pharmaceutical companies and venture capitalists, is driving research and development efforts in this domain. Nevertheless, the complexity of manufacturing processes may pose challenges to market growth.

Neoantigen Cancer Vaccine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 73.40% over the forecast period (2024-2032)

Based on Product segmentation, Personalized was predicted to show maximum market share in the year 2023

Based on Type segmentation, Nucleic Acid was the leading type in 2023

Based on Application segmentation, Lung Cancer was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Neoantigen Cancer Vaccine Market- Segmentation Analysis:

The Global Neoantigen Cancer Vaccine Market is segmented based on Product, Type, Route of Administration, Delivery Mechanism, Application, and Region.

The market is classified into two segments according to product: Personalized and Off-the-shelf. The Personalized segment holds a dominant position in the market. Personalized neoantigen vaccines are frequently used in conjunction with checkpoint inhibitors, such as PD-1 or CTLA-4 inhibitors, to enhance the immune response. This combinatorial strategy is under investigation to address the shortcomings of existing immunotherapies and to enhance patient outcomes.

The market is segmented into four categories according to type: Dendritic Cell, Nucleic Acid, Synthetic Long Peptide, and Tumor Cell. The Nucleic Acid category holds a leading position in the market. The Neoantigen Cancer Vaccine Market is significantly linked to progress in nucleic acid technologies, especially in the creation of novel vaccines aimed at addressing tumor-specific mutations.

The market is segmented into three categories according to the Route of Administration: Intramuscular, Intravenous, and Transdermal. The Neoantigen Cancer Vaccine Market is experiencing significant growth, with different routes of administration being essential for the advancement and distribution of these tailored therapies.

The market is categorized into four segments according to the Delivery Mechanism: Liposomes, Virosomes, Gene gun, Electroporation, and Others. These mechanisms are essential for effectively delivering personalized vaccines to the targeted cells, thereby facilitating a robust immune response to the cancer-specific neoantigens.

The market is segmented into four categories according to application: Brain Cancer, Gastrointestinal Cancer, Lung Cancer, Melanoma, and Others. Lung Cancer holds a leading position in the market. In the case of lung cancer, the elevated mutation burden offers a diverse range of potential neoantigens for targeting, thereby positioning personalized vaccines as a highly promising approach.

Neoantigen Cancer Vaccine Market- Geographical Insights

North America features a robust clinical trial framework, with a multitude of research institutions and hospitals engaged in the development of Neoantigen vaccines. The regulatory landscape in this region facilitates streamlined trial processes, promoting the advancement and evaluation of innovative therapies. Cancer has impacted nearly every individual in the United States, and there is significant public support for increased funding in cancer research. A recent survey conducted by ASCO, involving over 4,000 Americans, revealed that approximately 73% believe the government should allocate more resources to discovering treatments and cures for cancer, even if this necessitates higher taxes or an increase in the national deficit. Europe represents the second largest region for market expansion, driven by advancements in genomic technologies. Overall, the global environment for Neoantigen cancer vaccines is vibrant, presenting numerous growth opportunities across different regions.

Neoantigen Cancer Vaccine Market- Competitive Landscape:

The Neoantigen cancer vaccine market exhibits a highly competitive environment, with major players actively utilizing cutting-edge technologies, establishing strategic alliances, and making significant investments in research and development. These companies are collaborating with research institutions, healthcare facilities, and other biotechnology firms to strengthen their R&D efforts and accelerate the creation of neoantigen vaccines. The competitive landscape is expected to change swiftly, driven by continuous technological advancements and a commitment to enhancing patient outcomes.

Recent Developments:

On September 10, 2024, OSE Immunotherapeutics SA announced the commencement of its international Phase 3 clinical trial, named 'Artemia,' for Tedopi, a therapeutic cancer vaccine based on neoepitopes intended for off-the-shelf application. This trial is aimed at providing second-line treatment for patients diagnosed with metastatic non-small cell lung cancer (NSCLC). The study has received review and approval from health authorities across 14 countries, including the US FDA, Canada, Europe, and the United Kingdom, marking a significant advancement in the registration process for Tedopi, in conjunction with the development of a companion diagnostic for HLA-A2 positive patients.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL NEOANTIGEN CANCER VACCINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • OSE Immunotherapeutics SA
  • Gritstone Bio Inc.
  • BioNTech SE
  • Hoffmann-La Roche Ltd.
  • Pfizer Inc.
  • Merck & Co. Inc.
  • Moderna Inc.
  • Avidea Technologies Inc.
  • Eli Lilly and Company
  • Vaccibody AS
  • Agenus Inc.
  • Novogene Co. Ltd.
  • ZIOPHARM Oncology Inc.
  • ISA Pharmaceuticals B.V.
  • BrightPath Biotherapeutics Co. Ltd.
  • Vaximm AG
  • Medigene AG
  • Genocea Biosciences Inc.
  • Advaxis Inc.
  • Nouscom AG
  • Others

GLOBAL NEOANTIGEN CANCER VACCINE MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Personalized
  • Off-the-shelf

GLOBAL NEOANTIGEN CANCER VACCINE MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Dendritic Cell
  • Nucleic Acid
  • Synthetic Long Peptide
  • Tumor Cell

GLOBAL NEOANTIGEN CANCER VACCINE MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019 - 2032

  • Intramuscular
  • Intravenous
  • Transdermal

GLOBAL NEOANTIGEN CANCER VACCINE MARKET, BY DELIVERY MECHANISM- MARKET ANALYSIS, 2019 - 2032

  • Liposomes
  • Virosomes
  • Gene gun
  • Electroporation
  • Others

GLOBAL NEOANTIGEN CANCER VACCINE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Brain Cancer
  • Gastrointestinal Cancer
  • Lung Cancer
  • Melanoma
  • Others

GLOBAL NEOANTIGEN CANCER VACCINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Neoantigen Cancer Vaccine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Neoantigen Cancer Vaccine Market Snippet by Product
    • 2.1.2. Neoantigen Cancer Vaccine Market Snippet by Type
    • 2.1.3. Neoantigen Cancer Vaccine Market Snippet by Route of Administration
    • 2.1.4. Neoantigen Cancer Vaccine Market Snippet by Delivery Mechanism
    • 2.1.5. Neoantigen Cancer Vaccine Market Snippet by Application
    • 2.1.6. Neoantigen Cancer Vaccine Market Snippet by Country
    • 2.1.7. Neoantigen Cancer Vaccine Market Snippet by Region
  • 2.2. Competitive Insights

3. Neoantigen Cancer Vaccine Key Market Trends

  • 3.1. Neoantigen Cancer Vaccine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Neoantigen Cancer Vaccine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Neoantigen Cancer Vaccine Market Opportunities
  • 3.4. Neoantigen Cancer Vaccine Market Future Trends

4. Neoantigen Cancer Vaccine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Neoantigen Cancer Vaccine Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Neoantigen Cancer Vaccine Market Landscape

  • 6.1. Neoantigen Cancer Vaccine Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Neoantigen Cancer Vaccine Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
    • 7.1.2. Personalized
    • 7.1.3. Off-the-shelf

8. Neoantigen Cancer Vaccine Market - By Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 8.1.2. Dendritic Cell
    • 8.1.3. Nucleic Acid
    • 8.1.4. Synthetic Long Peptide
    • 8.1.5. Tumor Cell

9. Neoantigen Cancer Vaccine Market - By Route of Administration

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Route of Administration, 2023 & 2032 (%)
    • 9.1.2. Intramuscular
    • 9.1.3. Intravenous
    • 9.1.4. Transdermal

10. Neoantigen Cancer Vaccine Market - By Delivery Mechanism

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Delivery Mechanism, 2023 & 2032 (%)
    • 10.1.2. Liposomes
    • 10.1.3. Virosomes
    • 10.1.4. Gene gun
    • 10.1.5. Electroporation
    • 10.1.6. Others

11. Neoantigen Cancer Vaccine Market - By Application

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 11.1.2. Brain Cancer
    • 11.1.3. Gastrointestinal Cancer
    • 11.1.4. Lung Cancer
    • 11.1.5. Melanoma
    • 11.1.6. Others

12. Neoantigen Cancer Vaccine Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Neoantigen Cancer Vaccine Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Neoantigen Cancer Vaccine Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.10. Italy
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.10.4. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.10.5. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.10.6. Italy Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
      • 12.3.10.7. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.11. United Kingdom
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.11.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.11.4. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.11.5. United Kingdom Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.11.6. United Kingdom Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
      • 12.3.11.7. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.12. France
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.12.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.12.4. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.12.5. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.12.6. France Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
      • 12.3.12.7. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.13. Russia
      • 12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.13.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.13.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.13.4. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.13.5. Russia Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
      • 12.3.13.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.14. Netherlands
      • 12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.14.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.14.3. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.14.4. Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.14.5. Netherlands Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
      • 12.3.14.6. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.15.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.16. Poland
      • 12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.16.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.16.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.16.4. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.16.5. Poland Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
      • 12.3.16.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.3.17. Rest of Europe
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.3.17.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.3.17.4. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.3.17.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.3.17.6. Rest of the Europe Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
      • 12.3.17.7. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Neoantigen Cancer Vaccine Key Manufacturers in Asia Pacific
    • 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.4.5. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.4.7. Asia Pacific Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
    • 12.4.8. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.9. India
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.9.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.9.4. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.9.5. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.9.6. India Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
      • 12.4.9.7. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.10. China
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.10.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.10.4. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.10.5. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.10.6. China Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
      • 12.4.10.7. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.14. Thailand
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.14.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.14.4. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.14.5. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.14.6. Thailand Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
      • 12.4.14.7. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.15. Indonesia
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.15.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.15.4. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.15.5. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.15.6. Indonesia Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
      • 12.4.15.7. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.4.17. Rest of APAC
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.4.17.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.4.17.4. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.4.17.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.4.17.6. Rest of APAC Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
      • 12.4.17.7. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 12.5. Latin America
    • 12.5.1. Overview
    • 12.5.2. Neoantigen Cancer Vaccine Key Manufacturers in Latin America
    • 12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.5.5. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.5.6. Latin America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.5.7. Latin America Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
    • 12.5.8. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Neoantigen Cancer Vaccine Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 12.6.15. Rest of MEA
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 12.6.15.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 12.6.15.4. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 12.6.15.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 12.6.15.6. Rest of MEA Market Size and Forecast, By Delivery Mechanism, 2019 - 2032 (US$ Million)
      • 12.6.15.7. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

13. Key Vendor Analysis- Neoantigen Cancer Vaccine Industry

  • 13.1. Competitive Dashboard
  • 13.2. Company Profiles
    • 13.2.1. OSE Immunotherapeutics SA
    • 13.2.2. Gritstone bio Inc.
    • 13.2.3. BioNTech SE
    • 13.2.4. Hoffmann-La Roche Ltd.
    • 13.2.5. Pfizer Inc.
    • 13.2.6. Merck & Co. Inc.
    • 13.2.7. Moderna Inc.
    • 13.2.8. Avidea Technologies Inc.
    • 13.2.9. Eli Lilly and Company
    • 13.2.10. Vaccibody AS
    • 13.2.11. Agenus Inc.
    • 13.2.12. Novogene Co. Ltd.
    • 13.2.13. ZIOPHARM Oncology Inc.
    • 13.2.14. ISA Pharmaceuticals B.V.
    • 13.2.15. BrightPath Biotherapeutics Co. Ltd.
    • 13.2.16. Vaximm AG
    • 13.2.17. Medigene AG
    • 13.2.18. Genocea Biosciences Inc.
    • 13.2.19. Advaxis Inc.
    • 13.2.20. Nouscom AG
    • 13.2.21. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us